CymaBay Therapeutics, Inc. 4
4 · CymaBay Therapeutics, Inc. · Filed Jun 30, 2017
Insider Transaction Report
Form 4
Dickinson Klara
SVP, Regulatory Affairs & QA
Transactions
- Award
Stock Option (right to buy)
2017-06-28+200,000→ 200,000 totalExercise: $5.50Exp: 2027-06-27→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest according to the following schedule: 25% of the shares subject to the option shall vest on June 26, 2018, and the remaining of the shares shall vest in equal monthly installments over the next 36 months.